Tag: Lupin

spot_imgspot_img

Lupin Gets U.S. FDA Approval for Ranluspec™ to Treat Retinal Disorders

Breaking News Dose Daily News Bureau Dose Daily News Bureau -
Lupin Limited has secured U.S. FDA approval for Ranluspec™ (ranibizumab-hkdz), an interchangeable biosimilar to Genentech’s Lucentis® — a milestone that reshapes patient access to sight-saving biologics across...

Beyond Generics: Lupin Limited’s Dapagliflozin Approval Highlights Strategic Depth in Chronic Care

Dose daily Dose Daily News Bureau Dose Daily News Bureau -

Lupin Partners with Spektus Pharma to Commercialise Novel Antidepressant in Canada

Dose daily Dose Daily News Bureau Dose Daily News Bureau -

Lupin and TB Alliance Collaborate on Delivering New TB and Mycobacterial Drugs

Dose daily Dose Daily News Bureau Dose Daily News Bureau -

Diabetic Care Revolution: Lupin Launches Emergency Kit

Dose daily Dose Daily News Bureau Dose Daily News Bureau -
Diabetic Care Revolution: Lupin Launches Emergency Kit PharmaGenDRx News Bureau-12th August,2025 Global pharmaceutical leader Lupin limited has announced the launch of Glucagon for Injection USP, 1mg/vial...